Toronto (July 8, 2013) — Borden Ladner Gervais LLP (BLG) has been recognized in the 2013 edition of LMG Life Sciences as a leader in the field of life sciences law. Specifically, the Firm was recognized for its expertise in the Intellectual Property and Finance & Transactional categories.

In addition, the guide recognized two BLG partners as “Life Science Stars”:

  • Jeffrey Graham, partner in the Toronto office and national leader of the Firm’s Life Sciences Group.
  • Alaka Chatterjee, PhD, partner in the Vancouver office.

“Our clients in the life sciences sector require a legal partner that has an in-depth understanding of the science and technology their businesses are built on, and the latest trends that are impacting them,” said Sean Weir, national managing partner of BLG. “This recognition affirms our commitment to providing clients with the high level of expertise and service they need to achieve the best possible results.”

In its first year of research in Canada, LMG Life Sciences recognizes the top firms and attorneys in life sciences. Its results are based on interviews and surveys conducted with partners and clients active in the market, as well as the review of public information.

About Borden Ladner Gervais LLP

Borden Ladner Gervais LLP (BLG) is a pre-eminent full-service, national law firm focusing on business law, commercial litigation and intellectual property solutions for our clients. With more than 750 lawyers, intellectual property agents and other professionals in six Canadian cities, BLG assists clients with their legal needs, from major litigation to financing and patent registration.

— 30 —

For more information or to arrange an interview, please contact

Amanda McWhirter
Borden Ladner Gervais LLP